Area of research
Biomaterials · Biomedical Engineering
Research interest
Research focused on Cancer research and Chemotherapy, with related work in Medulloblastoma, Phosphodiesterase, Esophageal adenocarcinoma. Notable publications include 'Does age matter? The impact of rodent age on study outcomes', 'Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts', and 'ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastoma'.
Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts
ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastoma
Corrigendum to: ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastoma
Modulation of the Tumor Promoting Functions of Cancer Associated Fibroblasts by Phosphodiesterase Type 5 Inhibition Increases the Efficacy of Chemotherapy in Human Preclinical Models of Esophageal Adenocarcinoma
Modulation of the tumour promoting functions of cancer associated fibroblasts by phosphodiesterase type 5 inhibition increases the efficacy of chemotherapy in human preclinical models of esophageal adenocarcinoma
Modulation of the tumour promoting functions of cancer associated fibroblasts by phosphodiesterase type 5 inhibition increases the efficacy of chemotherapy in human preclinical models of esophageal adenocarcinoma
Does age matter? The impact of rodent age on study outcomes